City of Hope launched a national clinical trials model to accelerate access to emerging cancer therapies. Belgian bioinformatics firm Aspect Analytics raised €10 million to enhance spatial biology data analysis with AI/ML. Eli Lilly’s TuneLab AI platform boosts biotech drug discovery collaborations. Corsera Health raised $50 million to develop RNAi cardiometabolic treatments empowered by AI-based risk stratification tools, signaling a shift towards data-driven precision medicine and scalable clinical trial approaches.